Robert knight md biography

Immunotherapy Veteran Robert Knight, MD, Joins NexImmune as Chief Medical Officer

GAITHERSBURG, Md., Jan. 18, 2021 (GLOBE NEWSWIRE) -- NexImmune today announced the appointment of Dr. Robert (Bob) Knight as Chief Medical Officer (CMO). Dr. Knight is a seasoned executive with extensive experience leading early- and late-stage immunotherapy product development teams. Prior to joining NexImmune, Dr. Knight led the Yescarta® clinical program at Kite Pharmaceuticals (a Gilead Company) and, prior to that, spent 16 years at Celgene Corporation as a Vice President in Clinical Research. During his tenure at Celgene, he helped lead the development of the company’s IMiD and targeted therapy programs, including thalidomide, lenalidomide, and enasidenib. In addition to his roles at Kite and Celgene, Dr. Knight also led the cancer immunotherapy development program at Sorrento Therapeutics as the company’s Senior Vice President and Head of Clinical Research.

“We are excited to welcome Bob to the NexImmune team,” said Scott Carmer, NexImmune Chief Executive Officer. “Throughout his biopharmac

Robert T. Knight, M.D.

Insights into Human Cognition from Intracranial Recording

The last decade has witnessed an explosion of research employing recording of electrical activity directly from the human brain. Intracranial recording provides a powerful window into the neural basis of cognition and has been applied to a host of human behaviors. The first key finding was that the human brain generates robust neural activity up to 250 Hz (high frequency band; HFB) with exquisite spatial (millimeter) and temporal (millisecond) resolution. The second important observation was that HFB activity is modulated by slower cortical oscillations with different tasks eliciting unique sub-second distributed spatial-temporal activity patterns. I will first discuss how intracranial recording has provided novel insights into the neural basis of attention, language, memory and decision-making with the intracranial findings often challenging prior dogma in the field. I will then review our efforts using HFB activity to decode imagined speech in an effort to develop a brain computer interface for

Robert T. Knight

American neurologist and academic

Robert Thomas Knight is an American neurologist and Professor of Psychology and Neuroscience (UC Berkeley) as well as Neurology and Neurosurgery (UC San Francisco). His work is focused on attention and memory, neuropsychology, physiology, and cognitive neuroscience. He is an Elected Fellow of the American Academy of Arts & Sciences.[1]

Early life

Knight was born and raised in New Jersey.[2] Knight has one brother, who is a botanist.[2] He received a BS in Physics from the Illinois Institute of Technology and a M.D. from Northwestern University.[3] After medical school, he did a residency in neurology at UC San Diego followed by postdoctoral research at the Salk Institute. From 1980–1998 he was a Professor in the Neurology Department at UC Davis. Since 2000 he has been a professor at UC Berkeley in the Department of Psychology, and he served as the Director of the UC Berkeley Helen Wills Neuroscience Institute from 2001 to 2011.[4]

Awards

Knight has r

Copyright ©soybeck.pages.dev 2025